An Open-label Study of the Effects of Elagolix in Adult Premenopausal Females
Clinical trial NCT01403038 · COMPLETED
Trial details
- NCT number
- NCT01403038
- Sponsor
- AbbVie (prior sponsor, Abbott)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-06-01
- Primary completion
- 2012-10-01
- Enrollment
- 216
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.